Intralytix
Baltimore, US · Maryland corporation
Find your way into Intralytix
Sign up to see every warm intro you have to Intralytix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intralytix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Intralytix develops bacteriophage-based products for food safety, sanitation, consumer products, and human therapeutics targeting antibiotic-resistant pathogens. Its work spans FDA-cleared food safety products and clinical-stage therapeutics developed with academic partners.
Founders & leadership


Board
Reported raises · per SEC filings
Form D private placements$17.5M disclosed across 1 round · 2017
▶$17.5MraisedJun 2017 · 1 investors · OtherRule 506(b)
- Gary PasterneckDirector
- John J WoloszynExecutive Officer, Director
- Alexander SulakvelidzeExecutive Officer, Director
- Mel RuzickaExecutive Officer
- Patrick HervyDirector
- Offering amount
- $17.5M
- Amount sold
- $17.5M
- Proceeds to insiders
- $1.9M
- First sale
- May 2017
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $299.7K |
| Department of Agriculture (USDA) | Phase I | 2021 | $100K |
| Department of Agriculture (USDA) | Phase II | 2015 | $500K |
| Department of Agriculture (USDA) | Phase I | 2013 | $100K |
| Department of Agriculture (USDA) | Phase II | 2012 | $449.9K |
| U.S. ArmyArmy | Phase IISTTR | 2011 | $750K |
| Department of Agriculture (USDA) | Phase I | 2011 | $100K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase ISTTR | 2009 | $100K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase ISTTR | 2009 | $100K |
| U.S. ArmyArmy | Phase II | 2007 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $269.2K |
| U.S. ArmyArmy | Phase I | 2006 | $120K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2000 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Intralytix do?
- Intralytix develops bacteriophage-based products for food safety, sanitation, consumer products, and human therapeutics targeting antibiotic-resistant pathogens. Its work spans FDA-cleared food safety products and clinical-stage therapeutics developed with academic partners.
- Who founded Intralytix?
- Intralytix was founded by Alexander Sulakvelidze.
- How much funding has Intralytix raised?
- Intralytix has disclosed $17.5M raised across 1 round.
- Where is Intralytix headquartered?
- Intralytix is headquartered in Baltimore, US.
